Cargando…
High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells
BACKGROUND: Clevudine is a nucleoside analog reverse transcriptase inhibitor that exhibits potent antiviral activity against hepatitis B virus (HBV) without serious side effects. However, mitochondrial myopathy has been observed in patients with chronic HBV infection taking clevudine. Moreover, the...
Autores principales: | Jang, Yoon-Ok, Quan, Xianglan, Das, Ranjan, Xu, Shanhua, Chung, Choon-Hee, Ahn, Chan Mug, Baik, Soon-Koo, Kong, In Deok, Park, Kyu-Sang, Kim, Moon Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288815/ https://www.ncbi.nlm.nih.gov/pubmed/22230186 http://dx.doi.org/10.1186/1471-230X-12-4 |
Ejemplares similares
-
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients
por: Tak, Won Young, et al.
Publicado: (2014) -
Clevudine Induced Mitochondrial Myopathy
por: Park, Soo-Hyun, et al.
Publicado: (2017) -
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
por: Cho, Eun Young, et al.
Publicado: (2017) -
Efficacy of Initial Treatment with Clevudine in Naive Patients with Chronic Hepatitis B
por: Yang, Hyeon Woong, et al.
Publicado: (2010) -
Long-Term Treatment Efficacy and Safety of Clevudine Therapy in Naïve Patients with Chronic Hepatitis B
por: Choung, Bum Su, et al.
Publicado: (2012)